1. Epidemiology and clinical manifestations of mucormycosis;Petrikkos;Clin Infect Dis,2012
2. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), report 1;Sen;Indian J Ophthalmol,2021
3. Multicenter case-control study of COVID-19-associated mucormycosis outbreak, India;Muthu;Emerg Infect Dis,2023
4. AIIMS/ICMR-COVID-19 National Task Force/ Joint Monitoring Group (Dte.GHS), Ministry of Health & Family Welfare, Government of India. Clinical guidance for management of adult covid-19 patients. Published online January 5, 2023. Accessed May 10, 2023. https://www.icmr.gov.in/pdf/covid/techdoc/COVID_Clinical_Management_19032023.pdf
5. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries;Rudramurthy;Mycoses,2021